Rexahn Pharmaceuticals (RNN)
Rexahn Pharmaceuticals Income Statement
- Quarterly: March 2012 - December 2009 Previous Quarters
- Annual
| Income | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Revenue | 0.0188M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | ||||
| Cost of Revenue | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Gross Profit | 0.0188M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | ||||
| Research & Development Expense | 1.043M | 1.466M | 2.372M | 5.436M | 2.718M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Selling, General, & Admin. Expense | 0.8308M | 0.9086M | 0.9727M | 1.031M | 1.182M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Depreciation & Amortization | 0.0107M | 0.0102M | 0.0101M | 0.0107M | 0.0141M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Operating Interest Expense | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Operating Income (Expense) | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Total Operating Expenses | 1.884M | 2.385M | 3.355M | 6.477M | 3.913M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Operating Income | -1.884M | -2.385M | -3.355M | -6.459M | -3.913M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Non-Operating Income | -0.2556M | 2.793M | 1.886M | 0.6297M | -0.5228M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Pretax Income | -2.140M | 0.3893M | -1.469M | -5.829M | -4.436M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Provision for Income Taxes | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Income after Tax | -2.140M | 0.3893M | -1.469M | -5.829M | -4.436M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Minority Interest | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Minority Interest | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Equity In Affiliates | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Income Before Extraordinaries & Disc. Operations | -2.140M | 0.3893M | -1.469M | -5.829M | -4.436M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Investment Gains/Losses | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Income/Charges | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Income from Discontinued Operations | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Net Income | -2.140M | 0.3893M | -1.469M | -5.829M | -4.436M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Earnings Per Share Data | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Average Shares to compute diluted EPS | 95.35 | 93.05 | 95.24 | 95.24 | 86.25 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Average Shares used to compute basic EPS | 95.35 | 93.05 | 95.24 | 95.24 | 86.25 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| EPS - Basic net | -0.02 | 0.01 | -0.02 | -0.06 | -0.05 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| EPS - Diluted net | -0.02 | 0.01 | -0.02 | -0.06 | -0.05 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
